4 Antipsychotics
T | F | |
---|---|---|
1. Atypical antipsychotics have a longer D2 receptor occupancy than typical antipsychotics. | ||
2. Clozapine is a potent D2 antagonist. | ||
3. Clozapine dissociates from D2 receptors slowly. | ||
4. Clozapine antagonizes D3 and D4 receptors. | ||
5. Clozapine causes less postural hypotension than typical antipsychotics. | ||
6. Clozapine produces less sedation than typical antipsychotic drugs. | ||
7. Clozapine is contraindicated in the elderly. | ||
8. The risk of clozapine-induced seizures is dose-related. | ||
9. Aripiprazole is a D2 partial agonist. | ||
10. Olanzapine causes diabetes mellitus only at doses above 20 mg. | ||
11. Quetiapine causes clinically significant hyperprolactinaemia. | ||
12. Quetiapine has antihistaminic properties. | ||
13. Quetiapine has a half-life of 6 hours. | ||
14. Risperidone induces less akathisia than clozapine. | ||
15. Akathisia usually starts within a week of initiating treatment with antipsychotics. | ||
16. Neuroleptic malignant syndrome is characterized by gradual onset. | ||
17. Neuroleptic malignant syndrome is associated with clear consciousness. | ||
18. Neuroleptic malignant syndrome can be treated with a combination of a dopamine agonist and a calcium channel blocker. | ||
19. Tardive dyskinesia can occur in antipsychotic naïve patients. | ||
20. The prevalence of tardive dyskinesia in people on long-term antipsychotic treatment is more than 50%. | ||
21. Tardive dyskinesia disappears during sleep. | ||
22. Procyclidine can cause visual hallucinations. | ||
23. Physical dependence can occur in long-term procyclidine use. | ||
24. Antimuscarinic drugs are useful in the treatment of acute dystonia. | ||
25. Bradykinesia responds better to antimuscarinic drugs than rigidity. |